[en] summarY : mifepristone is one of the most common selective progesterone receptor modulator. its use in abortion in first and second trimester of pregnancy is well known. this type of molecule has also been studied in several diseases such as endometriosis, myomas, breast cancer and meningioma. only practical management of abortion using mifepristone will be
described here.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics)
Author, co-author :
FIRQUET, Anne ; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique CHR
BELIARD, Aude ; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique CHR
Chabbert-Buffet, N
PINTIAUX, Axelle ; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique CHR
Foidart, Jean-Michel ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique
Language :
English
Title :
L’interruption médicamenteuse de grossesse : applications cliniques de la mifépristone et des prostaglandins.
Publication date :
2011
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Gagne, D., Pons, M., Philibert, D., RU 38486: A potent antiglucocorticoid in vitro and in vivo (1985) Journal of Steroid Biochemistry, 23 (3), pp. 247-251. , DOI 10.1016/0022-4731(85)90401-7
Benagiano, G., Bastianelli, C., Farris, M., Selective progesterone receptor modulators 1: Use during pregnancy (2008) Expert Opin Pharmacother, 9, pp. 2459-2472
Tang, O.S., Gemzell-Danielsson, K., Ho, P.C., Misoprostol: Pharmacokinetic profiles, effects on the uterus and side-effects (2007) Int J Gynaecol Obstet, 99, pp. 160-167
Chandra, S., Allen, V.M., Lee, W., Fanning, C.A., Young, B.C., The effect of vaginal pH on labor induction with vaginal misoprostol (2005) Journal of Maternal-Fetal and Neonatal Medicine, 17 (6), pp. 387-391. , DOI 10.1080/14767050500123863
Wedisinghe, L., Elsandabesee, D., Flexible mifepristone and misoprostol administration interval for first-trimester medical termination (2010) Contraception, 81, pp. 269-274
Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: A randomised trial (2000) BJOG, 107, pp. 524-530. , No authors listed. World health organisation task force on post-ovulatory methods of fertility regulation
Schaff, E.A., Eisinger, S.H., Stadalius, L.S., Franks, P., Gore, B.Z., Poppema, S., Low-dose mifepristone 200 mg and vaginal misoprostol for abortion (1999) Contraception, 59 (1), pp. 1-6. , DOI 10.1016/S0010-7824(98)00150-4, PII S0010782498001504
Lièvre, M., Sitruk-Ware, R., Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancy (2009) Contraception, 80, pp. 95-100
Piaggio, G., Van Look, P., Von Hertzen, H., Is there evidence for tripling the dose of 200 mg mifepristone for medical abortion? (2010) Contraception, 81, p. 265
Zhang, J., Gilles, J.M., Barnhart, K., Creinin, M.D., Westhoff, C., Frederick, M.M., A comparison of medical management with misoprostol and surgical management for early pregnancy failure (2005) New England Journal of Medicine, 353 (8), pp. 761-769. , http://content.nejm.org/cgi/reprint/353/8/761.pdf, DOI 10.1056/NEJMoa044064
Hamoda, H., Ashok, P.W., Flett, G.M.M., Templeton, A., Medical abortion at 64 to 91 days of gestation: A review of 483 consecutive cases (2003) American Journal of Obstetrics and Gynecology, 188 (5), pp. 1315-1319. , DOI 10.1067/mob.2003.267
Løkeland, M., Iversen, O.E., Dahle, G.S., Medical abortion at 63 to 90 days of gestation (2010) Obstet Gynecol, 115, pp. 962-968
Gonzalez, C.H., Vargas, F.R., Perez, A.B.A., Chong, A.K., Brunoni, D., Marques, D.M.J., Leone, C.R., De Almeida, J.C.C., Limb deficiency with or without Mobius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy (1993) American Journal of Medical Genetics, 47 (1), pp. 59-64
Neilson, J.P., Hickey, M., Vazquez, J., Medical treatment for early fetal death (less than 24 weeks) (2006) Cochrane Database Syst Rev, 3. , CD002253
Westendorp, I.C.D., Ankum, W.M., Mol, B.W.J., Vonk, J., Prevalence of Asherman's syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion (1998) Human Reproduction, 13 (12), pp. 3347-3350. , DOI 10.1093/humrep/13.12.3347
Sotiriadis, A., Makrydimas, G., Papatheodorou, S., Ioannidis, J.P.A., Expectant, medical, or surgical management of first-trimester miscarriage: A meta-analysis (2005) Obstetrics and Gynecology, 105 (5 I), pp. 1104-1113. , DOI 10.1097/01.AOG.0000158857.44046.a4
Trinder, J., Brocklehurst, P., Porter, R., Management of miscarriage: Expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial) (2006) BMJ, 332, pp. 1235-1240
Dalenda, C., Ines, N., Fathia, B., Two medical abortion regimens for late first-trimester termination of pregnancy: A prospective randomized trial (2010) Contraception, 81, pp. 323-327
